Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus

被引:0
|
作者
Christophe Bardin
Estelle Nobecourt
Etienne Larger
François Chast
Jean-Marc Treluyer
Saik Urien
机构
[1] Hôtel-Dieu,Pharmacy
[2] AP-HP,Pharmacology
[3] Hôtel-Dieu,Toxicology Department
[4] AP-HP,Diabetology Department
[5] CIC-0901 Inserm Necker-Cochin,undefined
[6] AP-HP,undefined
[7] EA-3620,undefined
[8] Université Paris Descartes,undefined
关键词
Metformin; Population pharmacokinetics; Obese patient; Size descriptors; Diabetology;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:961 / 968
页数:7
相关论文
共 50 条
  • [41] Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese
    Fingeret, M.
    Marques-Vidal, R.
    Vollenweider, R.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2018, 28 (10) : 1036 - 1044
  • [42] Duodeno-jejunal exclusion in the treatment of Type 2 Diabetes mellitus:: Report on the first 8 non-obese or moderately obese diabetic patients
    Sarmiento, JA
    Velázquez, HMB
    Vazquez, LA
    OBESITY SURGERY, 2005, 15 (05) : 727 - 727
  • [43] Impaired peripheral insulin sensitivity in non-obese Japanese patients with type 2 diabetes mellitus and fatty liver
    Furukawa, Yasuhiko
    Tamura, Yoshifumi
    Takeno, Kageumi
    Funayama, Takashi
    Kaga, Hideyoshi
    Suzuki, Ruriko
    Watanabe, Takahiro
    Kakehi, Saori
    Kanazawa, Akio
    Kawamori, Ryuzo
    Watada, Hirotaka
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (03): : 529 - 535
  • [44] Midazolam Pharmacokinetics in Obese and Non-obese Children and Adolescents
    Gade, Christina
    Sverrisdottir, Eva
    Dalhoff, Kim
    Sonne, Jesper
    Johansen, Mia Ostergaard
    Christensen, Hanne Rolighed
    Burhenne, Juergen
    Mikus, Gerd
    Holm, Jens Christian
    Lund, Trine Meldgaard
    Holst, Helle
    CLINICAL PHARMACOKINETICS, 2020, 59 (05) : 643 - 654
  • [45] Midazolam Pharmacokinetics in Obese and Non-obese Children and Adolescents
    Christina Gade
    Eva Sverrisdóttir
    Kim Dalhoff
    Jesper Sonne
    Mia Østergaard Johansen
    Hanne Rolighed Christensen
    Jürgen Burhenne
    Gerd Mikus
    Jens Christian Holm
    Trine Meldgaard Lund
    Helle Holst
    Clinical Pharmacokinetics, 2020, 59 : 643 - 654
  • [46] Type 2 diabetes in the non-obese children and adolescents in Bangladesh
    Sayeed, M. A.
    Mahtab, H.
    Banu, A.
    Khanam, P. A.
    Latif, Z. A.
    Ahmed, A. U.
    Nahar, J. S.
    Khatun, K.
    Khan, A. Azad
    DIABETOLOGIA, 2008, 51 : S175 - S175
  • [47] Defects in skeletal muscle subsarcolemmal mitochondria in a non-obese model of type 2 diabetes mellitus
    Lai, Nicola
    Kummitha, China
    Hoppel, Charles
    PLOS ONE, 2017, 12 (08):
  • [48] Alterations in Choline Metabolism in Non-Obese Individuals with Insulin Resistance and Type 2 Diabetes Mellitus
    Al-Sulaiti, Haya
    Anwardeen, Najeha
    Bashraheel, Sara S.
    Naja, Khaled
    Elrayess, Mohamed A.
    METABOLITES, 2024, 14 (08)
  • [49] Impact of metformin versus repaglinide on postprandial glycaemia and plasma lipoproteins in non-obese patients with type-2 diabetes mellitus (T2DM)
    Lund, S. S.
    Tarnow, L.
    Smidt, U. M.
    Frandsen, M.
    Pedersen, O.
    Parving, H-H.
    Vaag, A. A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 193 - 193
  • [50] Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients
    Dominique Hansen
    Paul Dendale
    Milou Beelen
    Richard A. M. Jonkers
    Annelies Mullens
    Luk Corluy
    Romain Meeusen
    Luc J. C. van Loon
    European Journal of Applied Physiology, 2010, 109 : 397 - 404